DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

CCL Products (India) Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·9 Oct 2026, 11:31 am

CCL Products (I)

CCL Products (India) Limited has informed the stock exchanges that it has received a certificate under the SEBI (Depositories and Participants) Regulations, 2018. This regulatory compliance confirms that the company has successfully completed the necessary formalities related to its depository operations and shareholding records.

For investors, this development is a standard procedural update that ensures the company's adherence to market regulations. It does not indicate any change in the company's operational status or financial performance. The receipt of this certificate is generally viewed as a routine administrative milestone that maintains the company's compliance with the Securities and Exchange Board of India (SEBI) norms.

Investors should monitor the company's future quarterly results and operational updates to gauge its performance. While this regulatory milestone is neutral in nature, it reinforces the company's commitment to corporate governance standards.